GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rayont Inc (OTCPK:RAYT) » Definitions » Capex-to-Revenue

Rayont (Rayont) Capex-to-Revenue : 0.21 (As of Mar. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Rayont Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Rayont's Capital Expenditure for the three months ended in Mar. 2023 was $-0.21 Mil. Its Revenue for the three months ended in Mar. 2023 was $0.98 Mil.

Hence, Rayont's Capex-to-Revenue for the three months ended in Mar. 2023 was 0.21.


Rayont Capex-to-Revenue Historical Data

The historical data trend for Rayont's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rayont Capex-to-Revenue Chart

Rayont Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Jun22
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.30 - 0.01 1.19

Rayont Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 2.47 0.29 0.01 0.21

Competitive Comparison of Rayont's Capex-to-Revenue

For the Packaged Foods subindustry, Rayont's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rayont's Capex-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Rayont's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Rayont's Capex-to-Revenue falls into.



Rayont Capex-to-Revenue Calculation

Rayont's Capex-to-Revenue for the fiscal year that ended in Jun. 2022 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-3.38) / 2.839
=1.19

Rayont's Capex-to-Revenue for the quarter that ended in Mar. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.205) / 0.98
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rayont  (OTCPK:RAYT) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Rayont Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Rayont's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Rayont (Rayont) Business Description

Traded in Other Exchanges
N/A
Address
228 Hamilton Avenue, 3rd Floor, Palo Alto, CA, USA, 94301
Rayont Inc is a clinical-stage life sciences company that holds the license for registering and commercializing Photosoft technology for the treatment of all cancers. This technology is an improved next-generation Photodynamic Therapy (PDT) that uses non-toxic photosensitizers and visible light in combination with oxygen to produce cytotoxic-reactive oxygen that kills malignant cells, shuts down tumors, and stimulates the immune system. It has been licensed in Australia, New Zealand, China, Malaysia, and Sub-Sahara Africa. It has generated revenue from digital learning solutions provided by Rayont Technologies.
Executives
Meng Leong Liew director 1313 N. GRAND AVE. #16, WALNUT CA 91789
Kha Foo Chin director, 10 percent owner, officer: President, Treasurer ROOM 1217 NORTH TOWER, CONORDIA PLAZA, NO 1 SCIENCE MUSEUM RD., TSIM SHA TSUI E, KOWLOON K3 NA